IL6 and inflammation: Then, Zurita-Turk et al. [53] demonstrated that mice administered either the non-invasive strain L. lactis MG1363 (pValac::IL-10) or the invasive strain L. lactis MG1363 FnBPA+ (pValac::IL-10) had decreased severity of DSS-induced intestinal inflammation likely due to increased IL-10 levels and decreased IL-6 levels, compared to the positive control for colitis.